Article in Fierce Biotech: The Evolving Alzheimer’s Disease Landscape
There have been major advances in Alzheimer’s disease research and development in the past two years alone. What are those breakthroughs and what’s in development
There have been major advances in Alzheimer’s disease research and development in the past two years alone. What are those breakthroughs and what’s in development
In this video, InMed’s CEO, Eric A. Adams, explains the neuritogenesis process and how this process is essential for neuronal signaling and healthy brain functioning.
In this article, read about the prevalence of age-related macular degeneration and InMed’s promising preclinical studies of INM-089, a small molecule drug candidate in development
© Copyright 2024 InMed Pharmaceuticals Inc.
"*" indicates required fields